Abstract:[Objective] To investigate the effects of semaphorin 6D (SEMA6D) on the proliferation and invasion of osteosarcoma cells and its mechanism. [Methods] MG63 cells were divided into blank control group (the Ctrl group), negative control group (the si-NC group) and the group transfected with si-RNA targeting SEMA6D (the si-SEMA6D group), and corresponding transfection was performed in vitro. The changes of proliferation, migration and invasion ability of MG63 cells were detected by CCK-8, cell scratch and Transwell invasion assay. In addition, western blot analysis was performed to detect the protein expression of downstream related signaling pathways. [Results] After 24 hours culture, there was no significant difference in CCK-8 among the three groups (P>0.05). At 48 hours and 72 hours, the Ctrl and si-NC groups were significantly higher than the si-SEMA6D groups in CCK-8 assay [(0.7±0.1) vs (0.7±0.1) vs (0.4±0.1), P<0.001; (1.7±0.1) vs (1.6±0.1) vs (1.0±0.1), P<0.001]. The Ctrl and si-NC groups were significantly higher than the si-SEMA6D group in Transwell invasion assay [(435.0±28.2) vs (400.7±41.4) vs (291.3±31.1), P=0.022]. At 24 hours and 48 hours, the Ctrl and si-NC groups had significantly higher scratch healing rate than the si-SEMA6D group [(48.8±3.3)% vs (40.6±3.4)% vs (16.6±2.4)%, P<0.001; (74.7±1.1)% vs (67.6± 3.0)% vs (49.5±2.3)%, P<0.001]. As consequence of western blot analysis, the Ctrl group and si-NC group were significantly increased compared with the si-SEMA6D group in protein expression levels of p-PI3K, p-AKT, p-P38 and MMP2 (P<0.05), although there were no significant differences in the expression levels of P13K, AKT, p38, Bcl-2 and Bax among the three groups (P>0.05). [Conclusion] SEMA6D silencing of osteosarcoma MG63 cells can inhibit cell proliferation, migration and invasion by inhibiting PI3K/AKT and p38-MAPK signaling pathways.